The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity.
Mobb
G E
GE
Department of Surgery, Leicester General Hospital, UK.
Whiting
P H
PH
Feehally
J
J
Veitch
P S
PS
Bell
P R
PR
D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003524:Cyclosporins / Q000009:adverse effects*; D004311:Double-Blind Method; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000379:methods*; D011453:Prostaglandins / Q000097:blood; D011982:Receptors, Prostaglandin / Q000187:drug effects*; D017482:Receptors, Thromboxane
D001713:Biphenyl Compounds; D003524:Cyclosporins; D006538:Heptanoic Acids; D011453:Prostaglandins; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; C060013:vapiprost